Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 61

Results For "APAC"

909 News Found

Strengthening the access to rare disease treatment in India
Healthcare | May 09, 2022

Strengthening the access to rare disease treatment in India

Takeda and United Nations Global Compact Network of India (UNGCNI) join hands


Lonza to sell processing plant in Quakertown, Pennsylvania
News | May 08, 2022

Lonza to sell processing plant in Quakertown, Pennsylvania

Upon closing, the Quakertown business will become an independent company called Microsize


IGSTC to propose joint AI initiative on healthcare and sustainability
Sustainability | May 05, 2022

IGSTC to propose joint AI initiative on healthcare and sustainability

This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems


Avantor to create a new manufacturing hub in Singapore
News | May 05, 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year


DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis
Biotech | May 05, 2022

DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis

This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India


Merck invests $110 million to expand production site in China
News | May 05, 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Moderna finalizes plan for long-term strategic partnership with Canada
Biotech | May 01, 2022

Moderna finalizes plan for long-term strategic partnership with Canada

Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually


BeiGene to open new site at Princeton, New Jersey
Biotech | May 01, 2022

BeiGene to open new site at Princeton, New Jersey

Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo